Surgical strategy for aortoesophageal fistula in the endovascular era

Objective

Aortoesophageal fistula (AEF) is relatively rare and usually life-threatening. Lots of strategies have so far been discussed for this entity including the role of endovascular repair. The aim of this study is to review our experiences and reconsider the surgical strategy for aortoesophageal fistula in the endovascular era.

Methods

This is a retrospective multicenter study. From 1995 to 2011, 10 aortoesophageal fistula cases were identified in four institutions. For all of these cases surgical procedures and results were retrieved from medical records.

Results

Six patients underwent open aortic repair and four patients underwent thoracic endovascular aortic repair (TEVAR) as a primary intervention. Three patients who underwent open aortic repair with esophagectomy and omental coverage in early phase, either as a primary intervention or performed after bridging TEVAR, showed 100 % 1-year survival. On the other hand, three patients with TEVAR alone did not survive more than 1 year without recurrence. One patient with bridging TEVAR underwent concomitant esophageal resection and conventional aortic graft replacement 2 days later, and simultaneous gastric tube reconstruction was performed with intact whole omentum covering the aortic prosthesis. This patient is doing well with no sign of infection at 1-year follow-up.

Conclusion

For AEF, TEVAR as a primary approach is quite useful to stabilize the patients’ condition. However, definitive aortic repair with omental coverage should be performed as early as possible as a next step. It may be one of the strategies for the treatment of AEF that concomitant esophageal resection and aortic graft replacement is performed with simultaneous gastric tube reconstruction with intact whole omentum after removing the stent graft, so far as the patient’s physical condition permits.     

主动脉病变腔内修复术中导入动脉的外科处理

目的 探讨主动脉病变腔内修复术中对于导入动脉的外科处理方式。方法 回顾性分析南方医科大学南方医院血管外科2001年1月至2007年12月63例主动脉腔内修复术病人的临床资料,其中主动脉夹层33例,腹主动脉瘤25例,主动脉假性动脉瘤5例。结果 导入动脉分别选用股总动脉57例,髂外动脉6例。动脉切口单纯修补38例,动脉成形后修补16例,内膜剥除加单纯修补4例,动脉部分切除后行端端吻合4例,人工血管置换1例。62例病人获得成功,1例术中死亡。所有成功施行腔内隔绝术的病人中,1例术后出现导入动脉假性动脉瘤,通过再次手术治愈;2例术后出现患侧下肢轻微缺血症状,经造影证实为吻合口狭窄,予以保守治疗治愈,其他病人未出现并发症。 结论 术前详尽的评估,术中仔细的保护,术后根据情况及时进行相应处理,可有效防治导入动脉相关的并发症。     

Surgical strategy for the treatment of aortoesophageal fistula

Objective

To present a surgical strategy for aortoesophageal fistula (AEF).

Management of infected grafts and mycotic aneurysms of the aorta using cryopreserved homografts

OBJECTIVE: To evaluate the efficacy of the treatment of infected prosthetic grafts and mycotic aneurysms of the aorta with cryopreserved homografts. MATERIALS AND METHODS: Between April 1994 and May 2002, 15 cryopreserved aortic homografts were used in 13 patients in the thoracic and abdominal aortic position with supplementary omental or pectoral muscle wrapping for infected grafts (n=11), and mycotic aneurysms (n=2) (mean age: 57.5). RESULTS: One patient died due to multiorgan failure and the other due to postoperative cerebral hemorrhage (15.38%). Another patient died four months after the operation due to septic arthritis, and coronary heart disease. Ten patients are still alive without evidence of infection (76.92%) during a follow up of 44+/-23.03 (range 4-71) months. CONCLUSION: The use of cryopreserved homografts with supplementary omentum and/or muscle flap coverage, assures an anatomical reconstruction with good results in this difficult group of patients.     

Mycotic aneurysm of the abdominal aorta with retroperitoneal abscess: successful endovascular repair

Mycotic aortic aneurysms are rare. Improved diagnostic procedures, appropriate antibiotic treatment, and safe surgical techniques have reduced the high mortality associated with bacterial aortitis. However, definite evidence-based conclusions with regard to the surgical strategy cannot be drawn from the data available in the published literature. We report successful endovascular repair of a mycotic abdominal aortic aneurysm. Endovascular treatment may offer a benefit, especially in critically ill patients.     

Paraplegia after endovascular repair of the thoracic and thoracoabdominal aorta

AIM: The aim of this study was to analyse the incidence and aetiology of paraplegia secondary to endovascular repair of the thoracic and thoracoabdominal aorta (TEVAR). METHODS: A retrospective study was conducted in the patients treated at our facility between March 1997 and April 2007. During this interval, 173 patients (163 men; median age: 62 years) underwent endovascular repair of the thoracic aorta. Indications for treatment were thoracic aortic aneurysms in 36 patients, thoracoabdominal aortic aneurysms in 33 patients, type B dissections in 43 patients, type A dissections in 5 patients, penetrating aortic ulcers in 31 patients, traumatic aortic transections in 9 patients, post-traumatic aortic aneurysms in 5 patients, aortobronchial fistulas in 8 patients, aortic patch ruptures in 2 patients, and an anastomotic aortic aneurysm in 1 patient. 101 procedures (58%) were conducted as emergency interventions while 72 were elective. Device design and implant strategy were chosen on the basis of an evaluation of morphology from a computed tomographic scan. Clinical assessment and imaging of the aorta (CT or magnetic resonance imaging) during follow up were performed prior to discharge, at 6 and 12 months, and then annually. RESULTS: A primary technical success was achieved in 170 patients (98%). The overall 30-day mortality rate was 9.2%. Length of follow-up ranged from 1 to 96 months, with a mean of 52 months. Paraplegia or paraparesis developed in 3 patients (1.7%). Two of these patients had a thoracoabdominal aortic aneurysm and the third a chronic expanding type B dissection, being treated with hybrid procedures. CONCLUSIONS: Endovascular repair of the thoracic and thoracoabdominal aorta is associated with a relatively low risk for postoperative paraplegia or paraparesis. Patients requiring long segment aortic coverage, and with prior aortic replacement are especially at risk.     

Surgical and endovascular flow disconnection of intracranial pial single-channel arteriovenous fistulae

INTRODUCTION: Intracranial pial single-channel arteriovenous (AV) fistulae are rare vascular lesions of the brain. They differ from AV malformations in that they lack a true "nidus" and are composed of one or more direct arterial connections to a single venous channel. They often are associated with a venous varix because of their high-flow nature. The pathological aspects of pial AV fistulae arise from their high-flow dynamics; therefore, we think that disconnection of the AV shunt is enough to obliterate the lesion, and that lesion resection is unnecessary. Flow disconnection can be accomplished via surgical or endovascular means. Certain lesions have angiogeometric configurations, however, that are unfavorable for endovascular treatment. We reviewed the experience in our combined neurosurgical and neuroendovascular unit in the treatment of patients with pial single-channel AV fistulae. METHODS: From 1991 to 1999, the combined neurovascular unit at the Massachusetts General Hospital treated nine consecutive patients with nontraumatic intracranial pial single-channel AV fistulae. Carotid-cavernous fistulae and vein of Galen malformations were excluded from this analysis. The combined neurovascular team planned the treatment strategy for each patient on the basis of the anatomic location and the angiogeometry of each lesion. We retrospectively reviewed the medical records, office charts, operative reports, endovascular reports, and x-rays for each patient. Radiographic outcome was assessed by use of posttreatment angiography. Clinical outcome was assessed by an independent nurse practitioner. RESULTS: A treatment strategy of flow disconnection was used in all nine patients and was accomplished surgically in six patients, endovascularly in two patients, and by combined techniques in one patient. All nine lesions were completely obliterated as demonstrated radiographically, including obliteration of the venous varices associated with three of the lesions. With a mean long-term clinical follow-up of 3.2 years (range, 0.3-8.4 yr), four patients were neurologically excellent with no deficits, two patients had pretreatment neurological deficits that did not worsen after treatment, one patient had transient dysphonia and dysphagia postoperatively that resolved, one patient had mild weakness after treatment, and one patient had moderate homonymous hemianopia after treatment. CONCLUSION: Single-channel pial AV fistulae can be treated by a strategy of flow disconnection. Resection of the lesion is not necessary. Flow disconnection can be accomplished either surgically or endovascularly; however, certain angiogeometric configurations are more favorable for surgical treatment. An experienced combined neurosurgical and neuroendovascular team can carefully determine the most appropriate treatment modality on the basis of patient-specific and angiospecific factors.     

Surgical repair of coarctation of the aorta in adults

We report the surgical treatment of coarctation of the aorta (CoA) in 3 adults, 2 women and 1 man, aged between 18 and 32 years old. All of the patients had blood pressure gradients higher than 70 mmHg between the upper and lower limbs. In 2 patients, we simply clamped the aorta and excised the CoA: while in the other patient, we excised the CoA using partial extracorporeal circulation with a femoro-femoral (F-F) bypass. Reconstruction was done by an end to end anastomosis in 2 patients and with an artificial tube graft in 1 patient who regulred the extended aortic arch repair. Postoperatively, the pressure gradients between the upper and lower limbs dropped to below 20 mmHg in intensive care unit (ICU). Two of the patients have now stopped taking antihypertensive drugs and the other patient is taking half the preoperative dose.     

Adenosine-induced cardiac arrest and EEG changes in patients with thoracic aorta endovascular repair

Background. We studied haemodynamic and metabolic variables,and cerebral function after cardiac arrest induced by high doseof adenosine in patients undergoing thoracic aorta endovascularrepair. Methods. Arterial blood pressure, blood gas values and EEG wererecorded continuously in 15 patients undergoing anaesthesia(isoflurane) for endovascular thoracic aorta repair. Cardiacarrest was induced by different doses of adenosine (Adrekar®,Sanofi-Synthelabo, Berlin, Germany; 0.4–1.8 mg kg^–1body weight). Serum concentrations of neurone-specific enolase(NSE) were determined before and after stent graft implantation.Neurological function was assessed before and after surgery. Results. After adenosine, the heart beat stopped immediatelyfor 18–58 s in close relation to the adenosine dose. EEGpower was significantly reduced to –57%, but reached normalvalues within 5 min after cardiac arrest. In particular, thefast alpha- and beta-EEG-frequencies sensitively reflected patients'EEG activity during the procedure. No intraoperative increasesin NSE concentrations, and no neurological dysfunctions aftersurgery, were observed. Conclusion. After adenosine-induced cardiac arrest, changesin haemodynamic variables and EEG power spectra reversed completelywithin 1 and 5 min, respectively, without persistent brain dysfunctionafter stent graft implantation.     

Combined fenestrated-branched endovascular repair of the aortic arch and the thoracoabdominal aorta

ObjectiveThe aim of our study was to evaluate patients who underwent extensive endovascular aortic stent graft coverage (from the aortic arch to abdominal aorta) in terms of early and midterm clinical outcomes.MethodsA retrospective multicenter study was undertaken. All patients were treated with extensive endovascular aortic stent graft coverage with fenestrated and branched endografts at three experienced endovascular centers.ResultsBetween 2012 and 2017, there were 33 patients (22 male [67%]) treated with a combination of fenestrated-branched stent grafts in the aortic arch and the thoracoabdominal aorta. Most of the patients (20/33 [61%]) had fenestrated-branched endovascular aneurysm repair (fb-EVAR) of the thoracoabdominal aorta as a second-stage procedure after thoracic arch (fb-Arch) repair, 10 had fb-Arch repair as the first procedure, and three patients had a single-stage procedure. The mean age was 67 ± 13 years, and the mean interval between procedures was 13 ± 12 months. For fb-Arch repair, 20 fenestrated and 13 branched devices were used; for fb-EVAR, 23 fenestrated, 5 branched, and 5 composite devices were used. The use of spinal drainage was more common in fb-EVAR (20/33 [61%]). Technical success was 100%. Mean hospital stay was 15 ± 13 days for fb-Arch repair and 12 ± 9 days for fb-EVAR. Two patients died in the hospital after fb-EVAR, resulting in a 30-day mortality of 6% (2/33). No deaths occurred during the fb-Arch repair component or in the single-stage cases. Four patients developed spinal cord injury (12%), 1 had permanent paraplegia (3%), and 2 patients had a neurologic event (1 stroke [3%] and 1 transient ischemic attack [3%]). Six patients (18%) died during a mean follow-up of 23 ± 17 months. The survival at 12 months after the second procedure was 72%, and the freedom from any reintervention was 82%. The 12-month freedom from reintervention was 87% for fb-Arch repair and 81% for fb-EVAR.ConclusionsExtensive endovascular coverage of the aorta for aortic disease seems to be a feasible procedure in experienced centers, with acceptable perioperative morbidity and mortality. Spinal cord ischemia appears acceptable despite extensive aortic coverage.     

Novel endovascular repair of the small thoracic aorta: customizing off-the-shelf endoluminal grafts

Treatment of the small thoracic aorta is not currently amenable to standard endovascular repair. New customized endovascular approaches are necessary for these patients who are not candidates, for open repair. We describe a novel endovascular repair of a thoracic aortic pseudoaneurysm associated with a prior coarctation repair.     

Early outcomes after elective and emergent endovascular repair of the thoracic aorta

BACKGROUND: Endovascular treatment of thoracic aortic pathology has emerged as a viable alternative to open surgical repair in both the elective and emergent settings. The aim of this study was to evaluate preoperative work-up, intra-operative strategy, and outcomes of endovascular stent-grafting of the thoracic aorta in patients undergoing elective repair and those undergoing emergent repair. METHODS: All patient information was obtained by a retrospective review of an established clinical database for all endovascular thoracic stent-graft cases. From October 1999 to August 2005, 70 patients were treated with endovascular stent-grafts for lesions of the thoracic aorta. Thirty-five patients had an elective endovascular procedure, and 35 patients had an emergent procedure. RESULTS: Thirty-five patients in the endovascular (EL) group were treated for aneurysm (n = 34) and type B dissection (n = 1). Thirty-five patients in the emergent (EM) group were treated for aneurysm (n = 10), intramural hematoma (n = 10), type B dissection (n = 7), traumatic rupture (n = 7), and aortoesophageal fistula (n = 1). Preoperative angiography was performed in 94.3% (33/35) of EL patients but in only 45.7% (16/35) EM patients (P < .005). The EM procedures had significantly shorter operative times, used lower contrast volumes, used fewer stent-graft components (mode 2, range 1 to 5 vs mode 1, range 1 to 3; P = .02), and spinal cerebrospinal fluid drains were used significantly less often (82.9% vs 57.1%, P = .04). Both groups had similar 30-day morbidity, mortality (0/35 EL vs 1/35 [2.9%] EM, P = .99), postoperative endoleak (9/35 [25.7%] EL vs 7/35 [20.0%] EM, P = .78), endovascular failure (3/35 [8.6%] EL vs 5/35 [14.3%] EM, P = .71), and patient survival. CONCLUSION: There are significant differences in the underlying pathology, preoperative evaluation, and operative course between elective and emergency treatment endovascular procedures for lesions of the thoracic aorta. Endovascular repair of thoracic aortic lesions can be accomplished with low perioperative mortality and morbidity rates, as well as acceptable endoleak and endovascular failure rates for both elective and emergency procedures.     

A systematic review of primary endovascular repair of the ascending aorta

Objective

Endovascular repair of the ascending aorta is currently limited to patients at high surgical risk with aortic diseases originating above the sinotubular junction. A number of different endovascular technologies and approaches have been used, although no consensus exists regarding a standardized technique. To better understand real-world endovascular approaches to the ascending aorta, we performed a comprehensive review of the types of endovascular aortic stents and associated vascular access used in repair of the ascending aorta.